Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis b Patients”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05905458
What this trial is testing

A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs)

Who this might be right for
Chronic Hepatitis B
Chengdu Suncadia Medicine Co., Ltd. 54
Not applicableUnknownNCT05786963
What this trial is testing

Comparison of Hepatus and FibroScan for Evaluation of Fibrosis and Steatosis

Who this might be right for
Chronic Hepatitis bNon-Alcoholic Fatty Liver Disease
Beijing Friendship Hospital 400
Not applicableStudy completedNCT05265026
What this trial is testing

Aerobic Exercise Training in Patients With Chronic Hepatitis B and Hepatic Steatosis

Who this might be right for
Hepatitis B, ChronicHepatic Steatosis
Rigshospitalet, Denmark 19
Post-approval studies (Phase 4)Study completedNCT02898922
What this trial is testing

Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-treatment Patients With Chronic Hepatitis C：An Open-label Control Study in China

Who this might be right for
Hepatitis B Vaccines
Shandong Province Centers for Disease Control and Prevention 300
Testing effectiveness (Phase 2)Ended earlyNCT05760703
What this trial is testing

Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis b
Staidson (Beijing) Biopharmaceuticals Co., Ltd 9
Post-approval studies (Phase 4)UnknownNCT02973646
What this trial is testing

Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor Detection

Who this might be right for
Chronic Hepatitis b
Third Affiliated Hospital, Sun Yat-Sen University 100
Not applicableUnknownNCT03210493
What this trial is testing

The Changes of Treg Cells Frequency and Function During Antiviral Therapy

Who this might be right for
Chronic Hepatitis B Infection
Beijing Ditan Hospital 120
Not applicableUnknownNCT01610115
What this trial is testing

HBV DNA Levels During Pregnancy in Chronic Hepatitis B

Who this might be right for
Hepatitis BPregnancy
Chang Gung Memorial Hospital 100
Not applicableStudy completedNCT00388674
What this trial is testing

Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Chronic Hepatitis B
Bristol-Myers Squibb 12,522
Not applicableUnknownNCT04519359
What this trial is testing

Biomarkers Guided Stopping NAs Treatment

Who this might be right for
Chronic Hepatitis b
Nanfang Hospital, Southern Medical University 195
Large-scale testing (Phase 3)UnknownNCT01220596
What this trial is testing

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hanyang University 228
Not applicableStudy completedNCT00146705
What this trial is testing

Long Term Follow-up of Pegylated-Interferon Alpha-2b

Who this might be right for
Chronic Hepatitis B
Foundation for Liver Research 266
Post-approval studies (Phase 4)WithdrawnNCT01727271
What this trial is testing

Compare Efficacy and Safety of Tenofovir Used Alone or in Combination With Pegylated Interferon Alpha-2b in Participants With Chronic Hepatitis B and Elevated Alanine Aminotransferase (MK-4031-384)

Who this might be right for
Hepatitis B
Merck Sharp & Dohme LLC
Post-approval studies (Phase 4)Study completedNCT02594293
What this trial is testing

Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC Therapy

Who this might be right for
Chronic Hepatitis B
Huashan Hospital 180
Large-scale testing (Phase 3)Study completedNCT03903796
What this trial is testing

Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic HBV Infection
Jiangsu Hansoh Pharmaceutical Co., Ltd. 963
Large-scale testing (Phase 3)Study completedNCT00640588
What this trial is testing

Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine

Who this might be right for
Hepatitis B, Chronic
Novartis Pharmaceuticals 30
Post-approval studies (Phase 4)Study completedNCT01787279
What this trial is testing

An Expanded Access Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Negative Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 59
Not applicableUnknownNCT06196632
What this trial is testing

Development and Validation of Models to Predict Functional Cure in Patients With CHB After Peg-IFN Based Therapy

Who this might be right for
Hepatitis B, Chronic
Qilu Hospital of Shandong University 1,000
Post-approval studies (Phase 4)Study completedNCT02598063
What this trial is testing

Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 255
Testing effectiveness (Phase 2)Study completedNCT02726789
What this trial is testing

Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Replicor Inc. 5
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation